AG˹ٷ

STOCK TITAN

[Form 4] Elanco Animal Health Incorporated Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 27 June 2025, Elanco Animal Health Inc. (ELAN) disclosed in a Form 4 that Executive Vice President of U.S. Pet Health & Global Digital Transformation Rajeev A. Modi received 98.9937 deferred stock units (DSUs) at a reference price of $14.29 under the company’s Executive Deferral and Stock Match Plan. Each DSU converts into one common share or its cash equivalent upon settlement after employment ends or in a predetermined future year. The award is classified as transaction code “A,� meaning it is a compensation grant rather than an open-market purchase. Modi now directly holds 6,460.6903 DSUs; no shares were sold or otherwise disposed. The grant is small—worth roughly $1.4 thousand—and does not materially alter insider ownership or the company’s share count, but it marginally reinforces management-shareholder alignment.

Il 27 giugno 2025, Elanco Animal Health Inc. (ELAN) ha comunicato tramite un Modulo 4 che il Vicepresidente Esecutivo della divisione U.S. Pet Health & Global Digital Transformation, Rajeev A. Modi, ha ricevuto 98,9937 unità azionarie differite (DSU) a un prezzo di riferimento di 14,29 $ nell'ambito del Piano Esecutivo di Differimento e Abbinamento Azionario dell'azienda. Ogni DSU si converte in un'azione ordinaria o nel suo equivalente in contanti al momento della liquidazione, che avviene dopo la cessazione dell'impiego o in un anno futuro predeterminato. L'assegnazione è classificata con il codice transazione “A�, indicando che si tratta di una concessione di compensi e non di un acquisto sul mercato aperto. Modi detiene ora direttamente 6.460,6903 DSU; non sono state vendute o cedute azioni. L'assegnazione è di entità modesta—del valore di circa 1,4 mila dollari—e non modifica in modo significativo la proprietà interna o il numero di azioni della società, ma rafforza lievemente l'allineamento tra management e azionisti.

El 27 de junio de 2025, Elanco Animal Health Inc. (ELAN) informó en un Formulario 4 que el Vicepresidente Ejecutivo de Salud de Mascotas en EE. UU. y Transformación Digital Global, Rajeev A. Modi, recibió 98,9937 unidades de acciones diferidas (DSU) a un precio de referencia de $14.29 bajo el Plan Ejecutivo de Diferimiento y Coinversión de Acciones de la compañía. Cada DSU se convierte en una acción ordinaria o su equivalente en efectivo al momento de la liquidación, que ocurre tras la finalización del empleo o en un año futuro predeterminado. La concesión está clasificada con el código de transacción “A�, lo que indica que es una asignación de compensación y no una compra en el mercado abierto. Modi ahora posee directamente 6,460.6903 DSU; no se vendieron ni dispusieron acciones. La concesión es pequeña—con un valor aproximado de $1,400—y no altera materialmente la propiedad interna ni el número de acciones de la empresa, pero refuerza ligeramente la alineación entre la gerencia y los accionistas.

2025� 6� 27�, Elanco Animal Health Inc. (ELAN)� Form 4� 통해 미국 반려동물 건강 � 글로벌 디지� 전환 담당 부사장 Rajeev A. Modi가 회사� 임원 지� � 주식 매칭 계획� 따라 98.9937개의 지� 주식 단위(DSU)� 기준 가� $14.29� 받았다고 공개했습니다. � DSU� 고용 종료 � 또는 미리 정해� 미래 연도� 정산 � 보통� 1� 또는 그에 상응하는 현금으로 전환됩니�. � 수여� 거래 코드 “A”로 분류되어, 공개 시장에서� 구매가 아닌 보상 부여임� 의미합니�. Modi� 현재 직접 6,460.6903 DSU� 보유하고 있으�, 주식은 판매되거� 처분되지 않았습니�. 이번 부여는 � 1,400달러 상당으로 규모가 작으�, 내부� 소유권이� 회사� 주식 수에 � 변화를 주지 않지� 경영진과 주주 간의 이해관� 일치� 약간 강화합니�.

Le 27 juin 2025, Elanco Animal Health Inc. (ELAN) a déclaré dans un formulaire 4 que le vice-président exécutif de la santé animale aux États-Unis et de la transformation digitale globale, Rajeev A. Modi, a reçu 98,9937 unités d’actions différées (DSU) à un prix de référence de 14,29 $ dans le cadre du plan exécutif de report et d’abonnement d’actions de la société. Chaque DSU se convertit en une action ordinaire ou son équivalent en espèces lors du règlement, après la fin de l’emploi ou à une date future prédéterminée. Cette attribution est classée sous le code de transaction « A », ce qui signifie qu’il s’agit d’une attribution de rémunération et non d’un achat sur le marché libre. Modi détient désormais directement 6 460,6903 DSU ; aucune action n’a été vendue ou cédée. Cette attribution est modeste—d’une valeur d’environ 1 400 dollars—et ne modifie pas de manière significative la détention des initiés ni le nombre d’actions de la société, mais elle renforce légèrement l’alignement entre la direction et les actionnaires.

Am 27. Juni 2025 gab Elanco Animal Health Inc. (ELAN) in einem Formular 4 bekannt, dass der Executive Vice President für U.S. Pet Health & Global Digital Transformation, Rajeev A. Modi, 98,9937 aufgeschobene Aktienanteile (DSUs) zu einem Referenzpreis von 14,29 $ im Rahmen des Executive Deferral and Stock Match Plans des Unternehmens erhalten hat. Jede DSU wird bei der Abwicklung nach Beendigung des Arbeitsverhältnisses oder in einem vorab festgelegten zukünftigen Jahr in eine Stammaktie oder deren Barwert umgewandelt. Die Zuteilung ist mit dem Transaktionscode „A� klassifiziert, was bedeutet, dass es sich um eine Vergütungszuwendung und keinen Kauf am offenen Markt handelt. Modi hält nun direkt 6.460,6903 DSUs; es wurden keine Aktien verkauft oder anderweitig veräußert. Die Zuteilung ist klein—mit einem Wert von etwa 1.400 US-Dollar—und ändert die Insider-Beteiligung oder die Aktienanzahl des Unternehmens nicht wesentlich, stärkt jedoch geringfügig die Ausrichtung zwischen Management und Aktionären.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor compensation grant; negligible market impact, neutral for valuation.

The Form 4 shows a routine equity-linked compensation grant of 99 DSUs to EVP Rajeev Modi, lifting his beneficial holdings to about 6.5 k units. The economic value (~$1.4 k) is immaterial relative to Elanco’s market cap, and the award settles in the future, so there is no immediate cash cost to the company or insider. Because the transaction is coded “A,� it does not signal open-market insider conviction. From an investor standpoint, the filing is largely non-impactful; it neither changes supply-demand dynamics nor conveys fresh information about operations or strategy. It simply documents ongoing executive compensation mechanics.

Il 27 giugno 2025, Elanco Animal Health Inc. (ELAN) ha comunicato tramite un Modulo 4 che il Vicepresidente Esecutivo della divisione U.S. Pet Health & Global Digital Transformation, Rajeev A. Modi, ha ricevuto 98,9937 unità azionarie differite (DSU) a un prezzo di riferimento di 14,29 $ nell'ambito del Piano Esecutivo di Differimento e Abbinamento Azionario dell'azienda. Ogni DSU si converte in un'azione ordinaria o nel suo equivalente in contanti al momento della liquidazione, che avviene dopo la cessazione dell'impiego o in un anno futuro predeterminato. L'assegnazione è classificata con il codice transazione “A�, indicando che si tratta di una concessione di compensi e non di un acquisto sul mercato aperto. Modi detiene ora direttamente 6.460,6903 DSU; non sono state vendute o cedute azioni. L'assegnazione è di entità modesta—del valore di circa 1,4 mila dollari—e non modifica in modo significativo la proprietà interna o il numero di azioni della società, ma rafforza lievemente l'allineamento tra management e azionisti.

El 27 de junio de 2025, Elanco Animal Health Inc. (ELAN) informó en un Formulario 4 que el Vicepresidente Ejecutivo de Salud de Mascotas en EE. UU. y Transformación Digital Global, Rajeev A. Modi, recibió 98,9937 unidades de acciones diferidas (DSU) a un precio de referencia de $14.29 bajo el Plan Ejecutivo de Diferimiento y Coinversión de Acciones de la compañía. Cada DSU se convierte en una acción ordinaria o su equivalente en efectivo al momento de la liquidación, que ocurre tras la finalización del empleo o en un año futuro predeterminado. La concesión está clasificada con el código de transacción “A�, lo que indica que es una asignación de compensación y no una compra en el mercado abierto. Modi ahora posee directamente 6,460.6903 DSU; no se vendieron ni dispusieron acciones. La concesión es pequeña—con un valor aproximado de $1,400—y no altera materialmente la propiedad interna ni el número de acciones de la empresa, pero refuerza ligeramente la alineación entre la gerencia y los accionistas.

2025� 6� 27�, Elanco Animal Health Inc. (ELAN)� Form 4� 통해 미국 반려동물 건강 � 글로벌 디지� 전환 담당 부사장 Rajeev A. Modi가 회사� 임원 지� � 주식 매칭 계획� 따라 98.9937개의 지� 주식 단위(DSU)� 기준 가� $14.29� 받았다고 공개했습니다. � DSU� 고용 종료 � 또는 미리 정해� 미래 연도� 정산 � 보통� 1� 또는 그에 상응하는 현금으로 전환됩니�. � 수여� 거래 코드 “A”로 분류되어, 공개 시장에서� 구매가 아닌 보상 부여임� 의미합니�. Modi� 현재 직접 6,460.6903 DSU� 보유하고 있으�, 주식은 판매되거� 처분되지 않았습니�. 이번 부여는 � 1,400달러 상당으로 규모가 작으�, 내부� 소유권이� 회사� 주식 수에 � 변화를 주지 않지� 경영진과 주주 간의 이해관� 일치� 약간 강화합니�.

Le 27 juin 2025, Elanco Animal Health Inc. (ELAN) a déclaré dans un formulaire 4 que le vice-président exécutif de la santé animale aux États-Unis et de la transformation digitale globale, Rajeev A. Modi, a reçu 98,9937 unités d’actions différées (DSU) à un prix de référence de 14,29 $ dans le cadre du plan exécutif de report et d’abonnement d’actions de la société. Chaque DSU se convertit en une action ordinaire ou son équivalent en espèces lors du règlement, après la fin de l’emploi ou à une date future prédéterminée. Cette attribution est classée sous le code de transaction « A », ce qui signifie qu’il s’agit d’une attribution de rémunération et non d’un achat sur le marché libre. Modi détient désormais directement 6 460,6903 DSU ; aucune action n’a été vendue ou cédée. Cette attribution est modeste—d’une valeur d’environ 1 400 dollars—et ne modifie pas de manière significative la détention des initiés ni le nombre d’actions de la société, mais elle renforce légèrement l’alignement entre la direction et les actionnaires.

Am 27. Juni 2025 gab Elanco Animal Health Inc. (ELAN) in einem Formular 4 bekannt, dass der Executive Vice President für U.S. Pet Health & Global Digital Transformation, Rajeev A. Modi, 98,9937 aufgeschobene Aktienanteile (DSUs) zu einem Referenzpreis von 14,29 $ im Rahmen des Executive Deferral and Stock Match Plans des Unternehmens erhalten hat. Jede DSU wird bei der Abwicklung nach Beendigung des Arbeitsverhältnisses oder in einem vorab festgelegten zukünftigen Jahr in eine Stammaktie oder deren Barwert umgewandelt. Die Zuteilung ist mit dem Transaktionscode „A� klassifiziert, was bedeutet, dass es sich um eine Vergütungszuwendung und keinen Kauf am offenen Markt handelt. Modi hält nun direkt 6.460,6903 DSUs; es wurden keine Aktien verkauft oder anderweitig veräußert. Die Zuteilung ist klein—mit einem Wert von etwa 1.400 US-Dollar—und ändert die Insider-Beteiligung oder die Aktienanzahl des Unternehmens nicht wesentlich, stärkt jedoch geringfügig die Ausrichtung zwischen Management und Aktionären.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last) (First) (Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY

(Street)
GREENFIELD IN 46140

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 06/27/2025 A 98.9937 (2) (2) Common Stock 98.9937 $14.29 6,460.6903 D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Latest SEC Filings

ELAN Stock Data

6.83B
491.24M
0.88%
100.87%
2.92%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
GREENFIELD